Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.
Saved in:
| Title: | Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET. |
|---|---|
| Authors: | Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy. Electronic address: alessandra.gennari@uniupo.it., Brain E; Department of Medical Oncology, Institut Curie-Hôpital René Huguenin, Saint-Cloud, France., De Censi A; Medical Oncology, E.O. Ospedali Galliera, Genova., Nanni O; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Wuerstlein R; Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany., Frassoldati A; Clinical Oncology, S. Anna University Hospital, Ferrara, Italy., Cortes J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Rossi V; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy., Palleschi M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Alberini JL; Nuclear Medicine Department Centre Georges-Francois Leclerc, Dijon Cedex, France., Matteucci F; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST) -'Dino Amadori', Meldola., Piccardo A; Department of Nuclear Medicine, E.O. Ospedali Galliera, Genoa., Sacchetti G; Division of Nuclear Medicine Unit, Maggiore University Hospital, Novara, Italy., Ilhan H; Department of Nuclear Medicine, LMU University Hospital, Munich, Germany., D'Avanzo F; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy., Ruffilli B; Department of Translational Medicine, University of Piemonte Orientale, Novara., Nardin S; Medical Oncology Unit 1, IRCCS-Ospedale Policlinico San Martino, Genoa., Monti M; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Puntoni M; Clinical and Epidemiological Research Unit, University Hospital of Parma, Parma., Fontana V; Department of Clinical Epidemiology, IRCSS Ospedale Policlinico San Martino, Genoa, Italy., Boni L; Department of Clinical Epidemiology, IRCSS Ospedale Policlinico San Martino, Genoa, Italy., Harbeck N; Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany. |
| Corporate Authors: | ET-FES Collaborative Group |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jun; Vol. 35 (6), pp. 549-558. Date of Electronic Publication: 2024 Feb 28. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38423389 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with <superscript>18</superscript>F-fluoroestradiol (<superscript>18</superscript>F-FES) CT/PET. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gennari+A%22">Gennari A</searchLink>; Department of Translational Medicine, University of Piemonte Orientale, Novara; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy. Electronic address: alessandra.gennari@uniupo.it.<br /><searchLink fieldCode="AU" term="%22Brain+E%22">Brain E</searchLink>; Department of Medical Oncology, Institut Curie-Hôpital René Huguenin, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22De+Censi+A%22">De Censi A</searchLink>; Medical Oncology, E.O. Ospedali Galliera, Genova.<br /><searchLink fieldCode="AU" term="%22Nanni+O%22">Nanni O</searchLink>; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Wuerstlein+R%22">Wuerstlein R</searchLink>; Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Frassoldati+A%22">Frassoldati A</searchLink>; Clinical Oncology, S. Anna University Hospital, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Cortes+J%22">Cortes J</searchLink>; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rossi+V%22">Rossi V</searchLink>; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Palleschi+M%22">Palleschi M</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Alberini+JL%22">Alberini JL</searchLink>; Nuclear Medicine Department Centre Georges-Francois Leclerc, Dijon Cedex, France.<br /><searchLink fieldCode="AU" term="%22Matteucci+F%22">Matteucci F</searchLink>; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST) -'Dino Amadori', Meldola.<br /><searchLink fieldCode="AU" term="%22Piccardo+A%22">Piccardo A</searchLink>; Department of Nuclear Medicine, E.O. Ospedali Galliera, Genoa.<br /><searchLink fieldCode="AU" term="%22Sacchetti+G%22">Sacchetti G</searchLink>; Division of Nuclear Medicine Unit, Maggiore University Hospital, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Ilhan+H%22">Ilhan H</searchLink>; Department of Nuclear Medicine, LMU University Hospital, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22D'Avanzo+F%22">D'Avanzo F</searchLink>; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Ruffilli+B%22">Ruffilli B</searchLink>; Department of Translational Medicine, University of Piemonte Orientale, Novara.<br /><searchLink fieldCode="AU" term="%22Nardin+S%22">Nardin S</searchLink>; Medical Oncology Unit 1, IRCCS-Ospedale Policlinico San Martino, Genoa.<br /><searchLink fieldCode="AU" term="%22Monti+M%22">Monti M</searchLink>; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Puntoni+M%22">Puntoni M</searchLink>; Clinical and Epidemiological Research Unit, University Hospital of Parma, Parma.<br /><searchLink fieldCode="AU" term="%22Fontana+V%22">Fontana V</searchLink>; Department of Clinical Epidemiology, IRCSS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Boni+L%22">Boni L</searchLink>; Department of Clinical Epidemiology, IRCSS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Harbeck+N%22">Harbeck N</searchLink>; Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ET-FES+Collaborative+Group%22">ET-FES Collaborative Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2024 Jun; Vol. 35 (6), pp. 549-558. <i>Date of Electronic Publication: </i>2024 Feb 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38423389 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.02.007 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 549 Titles: – TitleFull: Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gennari A – PersonEntity: Name: NameFull: Brain E – PersonEntity: Name: NameFull: De Censi A – PersonEntity: Name: NameFull: Nanni O – PersonEntity: Name: NameFull: Wuerstlein R – PersonEntity: Name: NameFull: Frassoldati A – PersonEntity: Name: NameFull: Cortes J – PersonEntity: Name: NameFull: Rossi V – PersonEntity: Name: NameFull: Palleschi M – PersonEntity: Name: NameFull: Alberini JL – PersonEntity: Name: NameFull: Matteucci F – PersonEntity: Name: NameFull: Piccardo A – PersonEntity: Name: NameFull: Sacchetti G – PersonEntity: Name: NameFull: Ilhan H – PersonEntity: Name: NameFull: D'Avanzo F – PersonEntity: Name: NameFull: Ruffilli B – PersonEntity: Name: NameFull: Nardin S – PersonEntity: Name: NameFull: Monti M – PersonEntity: Name: NameFull: Puntoni M – PersonEntity: Name: NameFull: Fontana V – PersonEntity: Name: NameFull: Boni L – PersonEntity: Name: NameFull: Harbeck N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2024 Jun Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1569-8041 Numbering: – Type: volume Value: 35 – Type: issue Value: 6 Titles: – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology Type: main |
| ResultId | 1 |